Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Oncology · Ductal Carcinoma In Situ

What Causes DCIS, and Which Risk Factors Can I Change?

At a Glance

DCIS has no single known cause: genetic changes make cells in a breast milk duct grow abnormally, while age, family history, inherited genes, dense breasts, prior chest radiation, and other factors can raise risk. Healthy habits may support health but cannot guarantee prevention or replace treatment.

There is no single proven cause for ductal carcinoma in situ (DCIS). DCIS means that there are abnormal cells confined to the lining of a milk duct in the breast, and it is noninvasive—meaning it has not spread beyond the duct into surrounding breast tissue. These cells developed because of a mutation (a change in their genetic instructions) that caused them to grow abnormally, but researchers do not always know exactly why this happens in a specific person [1]. Instead of absolute causes, doctors look at “risk factors”—traits or exposures associated with a higher chance of developing breast cancer and DCIS. Having a risk factor changes the probability of developing the condition, but it does not determine whether you will actually get it. Finding out about these factors can help you and your care team make informed decisions about your ongoing care and surveillance. Importantly, having a risk factor does not mean you caused your DCIS.

Risk Factors You Cannot Change

Many factors that increase the risk of breast cancer or DCIS are built into your biology or medical history.

  • Age: The risk of developing DCIS generally increases with age, with many diagnoses occurring in older adults [2].
  • Family History and Genetics: Having close relatives with breast or ovarian cancer increases your risk [3]. Certain inherited genetic mutations, such as those in the BRCA1, BRCA2, ATM, CHEK2, and PALB2 genes, increase the overall risk of breast cancer [4]. The relevance of any genetic result depends on the specific gene, your family history, and your clinical context.
  • Prior Chest Radiation: If you received radiation therapy to the chest area at a young age (such as for childhood cancer), your risk of developing breast cancer, including DCIS, is significantly higher [5][6].
  • Breast Density: Women with dense breasts—meaning they have more fibrous and glandular tissue than fatty tissue—have a higher risk of DCIS [7]. Dense breasts can also make it harder for standard mammograms to detect abnormal cells [8].
  • High-Risk Breast Lesions: A personal history of certain breast changes increases future breast cancer risk. This includes atypical ductal hyperplasia (ADH), which is a benign (non-cancerous) high-risk lesion. It also includes lobular carcinoma in situ (LCIS), which is a lobular neoplasia and risk marker; some types, like pleomorphic LCIS, may be managed similarly to noninvasive cancer [9][7].

Medical and Reproductive Factors

Your body’s lifetime exposure to estrogen plays a role in breast cancer risk. Factors like never giving birth or having your first child at an older age have been associated with increased risk [3][10].

Additionally, medical exposures like menopausal hormone replacement therapy have been linked to an increased risk of breast cancer in some studies [11]. The risk from hormone therapy depends on the formulation, duration, timing, and your baseline risk. Do not start, stop, or change hormone therapy without discussing the benefits and risks with your prescribing clinician.

Risk Factors You Can Influence

While you cannot control your genetics or age, certain lifestyle choices are linked to breast cancer risk. Adopting a healthy lifestyle may lower your overall breast cancer risk and improve your general health [12].

  • Weight: Being at a weight that is higher than what is healthy for you, particularly after menopause, is associated with an increased risk of breast cancer [13][14]. Weight loss is not a prerequisite for receiving excellent care, but maintaining a weight that feels healthy and sustainable for your body can support overall well-being.
  • Physical Activity: Regular exercise is associated with a lower risk of developing breast cancer [13][15].
  • Alcohol: While the evidence specific to DCIS is mixed, some studies link higher alcohol consumption to an increased risk of breast cancer overall [15][16]. Limiting alcohol intake is a standard recommendation for overall breast health.

Lifestyle Changes Are Not a Guarantee or Substitute for Treatment

It is crucial to understand that an association is not a proven cause. While healthy habits are beneficial for your overall well-being and may reduce your future risk, there is no lifestyle change that guarantees prevention or guarantees against a recurrence or a new breast cancer [12]. In fact, large clinical trials testing dietary changes, such as low-fat diets, did not show a direct reduction in DCIS risk [17]. Lifestyle changes are not a proven substitute for your recommended DCIS treatment. You should not blame yourself or your habits for your diagnosis.

Screening and Surveillance After Diagnosis

Routine screening can detect asymptomatic DCIS before it becomes invasive breast cancer [2], though it is important to know that not all DCIS will progress to invasive cancer even if left untreated. Screening also carries risks, such as false positives or the potential for overdiagnosis.

If you have already been diagnosed and treated for DCIS, your “screening” becomes an individualized surveillance plan. Your follow-up schedule will differ depending on whether you had breast-conserving surgery (lumpectomy) or a mastectomy. Depending on your personal risk factors—such as dense breasts, genetics, or past chest radiation—your doctor may recommend additional imaging like an MRI or ultrasound [7][6]. However, dense breasts alone do not automatically mean you need supplemental imaging; this decision depends on your overall risk, the reason for imaging, and your treatment plan [8]. Furthermore, if you notice a new breast lump, nipple discharge, skin or nipple change, or persistent focal breast symptom, you should seek evaluation even if you are not currently due for screening.

Common questions in this guide

Why does DCIS develop if there is no single known cause?
DCIS develops when genetic instructions in cells lining a breast milk duct change and cause abnormal growth. Researchers often cannot identify why that change happened in one person. A risk factor raises the probability of DCIS but does not prove what caused it in an individual.
Can my lifestyle cause DCIS?
No single lifestyle choice has been proven to cause DCIS. Associations involving alcohol use, body weight, or physical activity do not show that a particular habit caused one person’s diagnosis. Healthy changes can support overall health but should not be viewed as punishment or as a substitute for treatment.
Which DCIS risk factors can I change?
Factors you may be able to influence include physical activity, alcohol intake, and maintaining a weight that is healthy and sustainable for you, especially after menopause. These changes may lower overall breast cancer risk and support health, but they cannot guarantee prevention or prevent recurrence.
Which DCIS risk factors cannot I change?
Age, family history, inherited gene changes, prior chest radiation at a young age, breast density, and a history of high-risk lesions such as atypical ductal hyperplasia or LCIS are not fully controllable. Reproductive history and some past medical exposures can also affect risk. Having any of these factors does not mean you caused DCIS.
Do dense breasts or an inherited gene change mean I will get DCIS?
No. Dense breasts and inherited changes in genes such as BRCA1, BRCA2, ATM, CHEK2, or PALB2 can increase risk, but they do not determine whether DCIS will occur. Dense tissue can also make mammograms harder to interpret, so your clinician may consider your full risk profile when planning imaging.
Do I need an MRI or ultrasound after a DCIS diagnosis?
Not necessarily. Follow-up imaging depends on your treatment, breast density, genetic and family history, prior chest radiation, and overall risk; dense breasts alone do not automatically require supplemental imaging. A new lump, nipple discharge, skin or nipple change, or persistent focal symptom should be evaluated even if you are not due for routine imaging.
Could hormone therapy affect my breast cancer risk?
Menopausal hormone therapy has been associated with higher breast cancer risk in some studies, and the effect depends on the formulation, duration, timing, and your baseline risk. Do not start, stop, or change it without discussing the benefits and risks with your prescriber. Endocrine therapy after DCIS is a separate hormone-blocking treatment that may be considered to reduce future risk based on your pathology.

Get notified when new evidence is published on ductal breast carcinoma in situ.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Epidemiology of Ductal Carcinoma In Situ.

    Iatrakis G, Zervoudis S

    Chirurgia (Bucharest, Romania : 1990) 2021; (116(5 Suppl)):S15-S21.

    PMID: 34967307
  2. 2

    Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year.

    Jacklyn G, Morrell S, McGeechan K, et al.

    Breast (Edinburgh, Scotland) 2018; (37()):170-178 doi:10.1016/j.breast.2017.08.005.

    PMID: 28882419
  3. 3

    Risk factors for ductal carcinoma in situ: comparisons with invasive breast cancer.

    Abe JV, Fukui J, Wilkens LR, et al.

    Breast cancer research : BCR 2026; (28(1)).

    PMID: 41923252
  4. 4

    Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the Breast.

    Huang H, Couch RE, Karam R, et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research 2025; (31(1)):130-138 doi:10.1158/1078-0432.CCR-24-1884.

    PMID: 39513960
  5. 5

    Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study (CCSS).

    Henderson TO, Liu Q, Turcotte LM, et al.

    JAMA oncology 2022; doi:10.1001/jamaoncol.2022.4649.

    PMID: 36227603
  6. 6

    Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group.

    Mulder RL, Hudson MM, Bhatia S, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020; (38(35)):4194-4207 doi:10.1200/JCO.20.00562.

    PMID: 33078972
  7. 7

    Mammographic density as a predictor of invasive breast cancer and ductal carcinoma in situ in over six million South Korean women.

    Kim SH, Park GE, Bertrand KA, et al.

    Breast cancer research and treatment 2025; (211(2)):341-350 doi:10.1007/s10549-025-07648-z.

    PMID: 40019668
  8. 8

    Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.

    Siu AL,

    Annals of internal medicine 2016; (164(4)):279-96 doi:10.7326/M15-2886.

    PMID: 26757170
  9. 9

    Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysis.

    Baker J, Noguchi N, Marinovich ML, et al.

    Breast (Edinburgh, Scotland) 2024; (78()):103807 doi:10.1016/j.breast.2024.103807.

    PMID: 39270543
  10. 10

    Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women.

    Bertrand KA, Bethea TN, Rosenberg L, et al.

    Breast (Edinburgh, Scotland) 2020; (49()):108-114 doi:10.1016/j.breast.2019.10.009.

    PMID: 31786415
  11. 11

    Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.

    Mullooly M, Khodr ZG, Dallal CM, et al.

    American journal of epidemiology 2017; (186(12)):1329-1340 doi:10.1093/aje/kwx206.

    PMID: 28637226
  12. 12

    Healthy lifestyle index and the risk of ductal carcinoma in situ of the breast in the Women's Health Initiative.

    Peila R, Lane DS, Shadyab AH, et al.

    International journal of cancer 2022; (151(4)):526-538 doi:10.1002/ijc.34034.

    PMID: 35429338
  13. 13

    Risk factors for ductal carcinoma in situ of the breast in the UK Biobank cohort study.

    Peila R, Arthur R, Rohan TE

    Cancer epidemiology 2020; (64()):101648 doi:10.1016/j.canep.2019.101648.

    PMID: 31837535
  14. 14

    Metabolic Syndrome and the Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank.

    Peila R, Rohan TE

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2024; (33(2)):333-336 doi:10.1158/1055-9965.EPI-23-0846.

    PMID: 37955559
  15. 15

    Comparison of the association of mammographic density and clinical factors with ductal carcinoma in situ versus invasive ductal breast cancer in Korean women.

    Ko H, Shin J, Lee JE, et al.

    BMC cancer 2017; (17(1)):821 doi:10.1186/s12885-017-3841-0.

    PMID: 29207971
  16. 16

    Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort.

    Puvanesarajah S, Gapstur SM, Gansler T, et al.

    Cancer causes & control : CCC 2020; (31(1)):95-103 doi:10.1007/s10552-019-01253-4.

    PMID: 31802322
  17. 17

    Low-Fat Dietary Modification and Risk of Ductal Carcinoma In Situ of the Breast in the Women's Health Initiative Dietary Modification Trial.

    Peila R, Chlebowski R, Manson JE, et al.

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2021; (30(9)):1753-1756 doi:10.1158/1055-9965.EPI-21-0404.

    PMID: 34187856

This page is for informational purposes only and does not constitute medical advice. It cannot determine why your DCIS developed; discuss your personal risk factors, surveillance, and treatment with your breast care team.